Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Operating Leases (2019 - 2026)

Argenx Se's (ARGX) quarterly Operating Leases came in at $36.0 million in Q2 2026, down 99.9% on a YoY basis from $35.6 billion in Q2 2025, and little changed quarter-over-quarter from $36.0 million in Q4 2025.

Analysis

Argenx Se (ARGX) Operating Leases (2019 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Operating Leases for 8 consecutive years, with $36.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases fell 99.9% year-over-year to $36.0 million; the trailing twelve-month figure through Jun 2026 stood at $36.0 million (down 99.9% YoY), and the FY2025 full-year result was $36.0 million, down 99.89% from the prior year.
  • Operating Leases steadied at $36.0 million in Q2 2026 per ARGX's latest filing, from $36.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $35.6 billion in Q2 2025 and bottomed at $6.2 million in Q2 2022.
  • Historically, Operating Leases has averaged $8.6 billion across 5 years, with a median of $36.0 million in 2025.
  • The sharpest annual moves came in 2024 and 2026: Operating Leases soared 211701.48% in 2024, then sank 99.9% in 2026.
  • Over 5 years, Operating Leases stood at $9.0 billion in 2022, then tumbled by 99.83% to $15.4 million in 2023, then jumped by 211701.48% to $32.5 billion in 2024, then slumped by 99.89% to $36.0 million in 2025, then changed by 0.0% to $36.0 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $36.0 million, $36.0 million, and $35.6 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.00 Mn
Dec 31, 2025 36.00 Mn
Jun 30, 2025 35.57 Bn
Dec 31, 2024 32.52 Bn
Jun 30, 2024 28.11 Mn
Dec 31, 2023 15.35 Mn
Jun 30, 2023 8.04 Mn
Dec 31, 2022 9.01 Bn
Jun 30, 2022 6.21 Mn
Dec 31, 2021 7.96 Bn
Jun 30, 2021 4.43 Mn
Dec 31, 2020 6.00 Bn
Jun 30, 2020 5.14 Mn
Dec 31, 2019 5.03 Mn
Jun 30, 2019 4.14 Mn
API Access

Argenx Se Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ARGX&period=max&api_key=YOUR_API_KEY